SALL1 and Townes-Brocks syndrome: The complete triad of TBS’s major clinical signs was present in only 3 out of 10 patients with SALL1 deletions (group 1: 30%) and in 12 out of 20 patients with the p.Arg276Ter mutation (group 2: 60%).